Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brandon A Mahal

Showing results (131-140 of 214) with videos related to

Pageof 22
Sort By:
The Prostate|September 16, 2021
Prostate tumors of native men from West Africa show biologically distinct pathways-A comparative genomic studyKosj Yamoah, Francis A Asamoah, Afua O D Abrahams, et al.
Prostate Cancer and Prostatic Diseases|January 13, 2022
Clinicogenomic characterization of prostate cancer liver metastasesMohammed Alshalalfa, Crystal Seldon, Idalid Franco, et al.
JAMA Network Open|April 2, 2020
Geographic Distribution of Racial Differences in Prostate Cancer MortalitySean A Fletcher, Maya Marchese, Alexander P Cole, et al.
Clinical Genitourinary Cancer|November 17, 2023
The Molecular, Immunologic, and Clinicodemographic Landscape of MYC-Amplified Advanced Prostate CancerWill H Jin, Liangliang Zhang, Ryon Graf, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 21, 2023
Unique Spectrum of Activating BRAF Alterations in Prostate CancerAlex Chehrazi-Raffle, Hanna Tukachinsky, Eamon Toye, et al.
Urology|September 23, 2015
Occult High-risk Disease in Clinically Low-risk Prostate Cancer with ≥50% Positive Biopsy Cores: Should National Guidelines Stop Calling Them Low Risk?Kathryn T Dinh, Vinayak Muralidhar, Brandon A Mahal, et al.
Cancers|February 13, 2025
Association Between Medicaid Expansion and Insurance Status, Risk Group, Receipt, and Refusal of Treatment Among Men with Prostate CancerTej A Patel, Bhav Jain, Edward Christopher Dee, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|September 6, 2019
Comparing the Association Between Insurance and Mortality in Ovarian, Pancreatic, Lung, Colorectal, Prostate, and Breast CancersAlexander P Cole, Chang Lu, Marieke J Krimphove, et al.
Journal of the American Academy of Dermatology|April 23, 2020
Surface applicator high-dose-rate fractionated brachytherapy for superficial cancers of the penis: A single-center case series and national database comparisonEdward Christopher Dee, Maia Fefer, Lubna Hammoudeh, et al.
Advances in Radiation Oncology|April 16, 2020
Prostate Cancer Radiation Therapy Recommendations in Response to COVID-19Nicholas G Zaorsky, James B Yu, Sean M McBride, et al.
Pageof 22

Showing results (131-140 of 214) with videos related to

Sort By:
Pageof 22
The Prostate|September 16, 2021
Prostate tumors of native men from West Africa show biologically distinct pathways-A comparative genomic studyKosj Yamoah, Francis A Asamoah, Afua O D Abrahams, et al.
Prostate Cancer and Prostatic Diseases|January 13, 2022
Clinicogenomic characterization of prostate cancer liver metastasesMohammed Alshalalfa, Crystal Seldon, Idalid Franco, et al.
JAMA Network Open|April 2, 2020
Geographic Distribution of Racial Differences in Prostate Cancer MortalitySean A Fletcher, Maya Marchese, Alexander P Cole, et al.
Clinical Genitourinary Cancer|November 17, 2023
The Molecular, Immunologic, and Clinicodemographic Landscape of MYC-Amplified Advanced Prostate CancerWill H Jin, Liangliang Zhang, Ryon Graf, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 21, 2023
Unique Spectrum of Activating BRAF Alterations in Prostate CancerAlex Chehrazi-Raffle, Hanna Tukachinsky, Eamon Toye, et al.
Urology|September 23, 2015
Occult High-risk Disease in Clinically Low-risk Prostate Cancer with ≥50% Positive Biopsy Cores: Should National Guidelines Stop Calling Them Low Risk?Kathryn T Dinh, Vinayak Muralidhar, Brandon A Mahal, et al.
Cancers|February 13, 2025
Association Between Medicaid Expansion and Insurance Status, Risk Group, Receipt, and Refusal of Treatment Among Men with Prostate CancerTej A Patel, Bhav Jain, Edward Christopher Dee, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|September 6, 2019
Comparing the Association Between Insurance and Mortality in Ovarian, Pancreatic, Lung, Colorectal, Prostate, and Breast CancersAlexander P Cole, Chang Lu, Marieke J Krimphove, et al.
Journal of the American Academy of Dermatology|April 23, 2020
Surface applicator high-dose-rate fractionated brachytherapy for superficial cancers of the penis: A single-center case series and national database comparisonEdward Christopher Dee, Maia Fefer, Lubna Hammoudeh, et al.
Advances in Radiation Oncology|April 16, 2020
Prostate Cancer Radiation Therapy Recommendations in Response to COVID-19Nicholas G Zaorsky, James B Yu, Sean M McBride, et al.
Pageof 22